Correlation Between Cytokinetics and Dyne Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cytokinetics and Dyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cytokinetics and Dyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cytokinetics and Dyne Therapeutics, you can compare the effects of market volatilities on Cytokinetics and Dyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cytokinetics with a short position of Dyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cytokinetics and Dyne Therapeutics.
Diversification Opportunities for Cytokinetics and Dyne Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cytokinetics and Dyne is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Cytokinetics and Dyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dyne Therapeutics and Cytokinetics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cytokinetics are associated (or correlated) with Dyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dyne Therapeutics has no effect on the direction of Cytokinetics i.e., Cytokinetics and Dyne Therapeutics go up and down completely randomly.
Pair Corralation between Cytokinetics and Dyne Therapeutics
Given the investment horizon of 90 days Cytokinetics is expected to under-perform the Dyne Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cytokinetics is 1.76 times less risky than Dyne Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Dyne Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 2,144 in Dyne Therapeutics on November 3, 2024 and sell it today you would lose (722.00) from holding Dyne Therapeutics or give up 33.68% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cytokinetics vs. Dyne Therapeutics
Performance |
| Timeline |
| Cytokinetics |
| Dyne Therapeutics |
Cytokinetics and Dyne Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cytokinetics and Dyne Therapeutics
The main advantage of trading using opposite Cytokinetics and Dyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cytokinetics position performs unexpectedly, Dyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne Therapeutics will offset losses from the drop in Dyne Therapeutics' long position.| Cytokinetics vs. Edgewise Therapeutics | Cytokinetics vs. Dyne Therapeutics | Cytokinetics vs. Stoke Therapeutics | Cytokinetics vs. Pliant Therapeutics |
| Dyne Therapeutics vs. Stoke Therapeutics | Dyne Therapeutics vs. Pliant Therapeutics | Dyne Therapeutics vs. Cytokinetics | Dyne Therapeutics vs. Revolution Medicines |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |